Lek Boasts 2006 Revenues of EUR 721m

Ljubljana, 19 January - Pharmaceutical company Lek, a subsidiary of Novartis's generic arm Sandoz, posted sales of EUR 721m for 2006, an increase of 33% over the year before. Lek said profits grew significantly, but it did not disclose the figures in Friday's press release.